National Jewish Health Welcomes Dr. Derek Abbott as Chair of Immunology and Genomic Medicine
Denver, CO – July 16, 2025 – National Jewish Health is pleased to announce that Derek Abbott, MD, PhD, has assumed his new role as Chair of the Department of Immunology and Genomic Medicine. This significant appointment underscores National Jewish Health’s commitment to advancing research and clinical care in these critical fields, known for their profound impact on patient health and disease understanding.
Dr. Abbott brings a wealth of expertise and a distinguished career marked by groundbreaking contributions to both immunology and genomic medicine. His leadership is expected to further strengthen National Jewish Health’s position as a leader in understanding the complex interplay between the immune system and an individual’s genetic makeup, particularly in the context of respiratory and immune-related diseases.
In his new capacity, Dr. Abbott will oversee the strategic direction and operational excellence of the Department of Immunology and Genomic Medicine. This includes fostering innovative research initiatives, cultivating a collaborative environment for scientists and clinicians, and driving the translation of cutting-edge discoveries into improved patient outcomes. His vision is anticipated to enhance the department’s capabilities in areas such as personalized medicine, the development of novel immunotherapies, and the deeper understanding of genetic predispositions to various diseases.
“We are incredibly fortunate to have Dr. Abbott join National Jewish Health,” said Dr. Michael Z. David, President and CEO of National Jewish Health. “His exceptional background and forward-thinking approach are precisely what we need to propel our work in immunology and genomic medicine to new heights. We are confident that under his leadership, our department will continue to make significant strides in improving the lives of patients facing challenging diseases.”
Dr. Abbott’s academic and research pursuits have been characterized by a deep commitment to unraveling the complexities of immune responses and the role of genomics in health and disease. His work has not only advanced scientific knowledge but has also laid the groundwork for new diagnostic and therapeutic strategies. The integration of genomic insights into the study of immunology promises to revolutionize how we approach and treat a wide spectrum of conditions.
The Department of Immunology and Genomic Medicine at National Jewish Health is at the forefront of research into diseases such as asthma, cystic fibrosis, autoimmune disorders, and infectious diseases. By merging the disciplines of immunology and genomic medicine, the department is uniquely positioned to explore the genetic underpinnings of immune system function and dysfunction, leading to more targeted and effective treatments.
Dr. Abbott’s arrival marks an exciting new chapter for National Jewish Health, reinforcing its dedication to pioneering research and providing world-class care. His leadership is poised to inspire a new generation of scientists and clinicians, further cementing the institution’s legacy of innovation and patient-centered excellence.
AI has delivered the news.
The answer to the following question is obtained from Google Gemini.
PR Newswire Policy Public Interest published ‘Derek Abbott, MD, PhD, Begins New Role as Chair of Immunology and Genomic Medicine at National Jewish Health’ at 2025-07-16 14:00. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.